Clicky

Verrica Pharmaceuticals Inc(1NE) News

Date Title
Oct 9 Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ...
Jul 29 3 High Insider Ownership US Stocks With Up To 52% Revenue Growth
May 9 Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
May 8 Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
May 6 Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
Dec 24 Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership
Aug 24 Verrica Pharmaceuticals Announces First Sale of YCANTH™ to FFF Enterprises
Aug 23 Verrica Issues Statement in Support of FDA’s Warning Letters to Manufacturers and Retailers for Producing and Selling Unapproved Products for the Treatment of Molluscum Contagiosum
Jul 21 UPDATE 2-Verrica's drug gets US nod as first treatment for a type of skin infection
Jul 21 Verrica Pharmaceuticals Announces FDA Approval of YCANTH™ (cantharidin) topical solution as the First FDA approved Treatment of Pediatric and Adult Patients with Molluscum Contagiosum
Jul 17 With a 39% stake, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders have a lot riding on the company